Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment

Kimberly Loh; Emily Rose; Sarah Tansley

doi:10.1093/rap/rkaf141

Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment

Kimberly Loh, Emily Rose, Sarah Tansley

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	rkaf141
Journal	Rheumatology Advances in Practice
Volume	10
Issue number	1
Early online date	6 Dec 2025
DOIs	https://doi.org/10.1093/rap/rkaf141
Publication status	Published - 31 Jan 2026

Data Availability Statement

This study represents a retrospective clinical audit conducted at the Royal National Hospital for Rheumatic Disease, Royal United Hospital, Bath. De-identified data underlying this article may be provided upon reasonable request to the corresponding author.

Funding

No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article.

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1093/rap/rkaf141Licence: CC BY

Cite this

@article{454a0747762049aea63753364da27047,

title = "Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment",

author = "Kimberly Loh and Emily Rose and Sarah Tansley",

year = "2026",

month = jan,

day = "31",

doi = "10.1093/rap/rkaf141",

language = "English",

volume = "10",

journal = "Rheumatology Advances in Practice",

issn = "2514-1775",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies

T2 - a call for improved, disease-specific risk assessment

AU - Loh, Kimberly

AU - Rose, Emily

AU - Tansley, Sarah

PY - 2026/1/31

Y1 - 2026/1/31

UR - https://www.scopus.com/pages/publications/105026365021

U2 - 10.1093/rap/rkaf141

DO - 10.1093/rap/rkaf141

M3 - Letter

AN - SCOPUS:105026365021

SN - 2514-1775

VL - 10

JO - Rheumatology Advances in Practice

JF - Rheumatology Advances in Practice

IS - 1

M1 - rkaf141

ER -

Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment

Data Availability Statement

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this